Vitamin E and Fatty Acid Intake and Cardiometabolic Multimorbidity Risk: The Mediating Role of Plasma Lipid Metabolites

维生素E和脂肪酸摄入量与心血管代谢多重疾病风险:血浆脂质代谢物的介导作用

阅读:3

Abstract

Cardiometabolic multimorbidity (CMM), defined as the co-occurrence of two or more of the following: diabetes, ischemic heart disease, stroke, and other cardiovascular diseases, is a leading cause of global mortality. Although vitamins and fatty acid are known to influence cardiometabolic diseases through lipid metabolism, the mediating role of lipid metabolites in linking dietary vitamins and fatty acid intake to CMM remains unclear. We conducted a case-control study based on the Ningxia cohort, including 200 patients with CMM and 200 age- and sex-matched controls. Dietary intake was assessed using a semi-quantitative food frequency questionnaire, and plasma lipid profiles were analyzed using ultra-performance liquid chromatography-tandem mass spectrometry. We assessed associations between dietary nutrients and CMM using logistic regression and their relationships with lipid metabolites via Pearson correlation. Mediation analysis identified lipid metabolites that link vitamin and fatty acid intake to CMM, and these mediators were incorporated into a predictive model. We found that higher intake of vitamin E (VE), total fatty acids (FA), polyunsaturated fatty acids (PUFA), and monounsaturated fatty acids (MUFA) was significantly associated with lower CMM risk (OR < 1, FDR ≤ 0.05). Lipid profiling identified 349 differentially abundant metabolites, primarily triglycerides and diglycerides, elevated in CMM patients. Mediation analysis revealed 292 significant pathways: dietary intake VE and PUFA was linked to lower CMM risk via modulation of glycerolipid metabolites, while dietary intake FA and MUFA was linked to lower risk through regulation of glycerophospholipids. A predictive model incorporating age, sex, dietary factors, and key mediating lipids achieved good discrimination (AUC: 0.765-0.812). These findings suggest that dietary intake of VE, FA, PUFA, and MUFA is associated with reduced CMM risk through modulation of plasma lipid metabolism, with specific lipid metabolites potentially acting as key mediators.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。